Unexpected individual clinical site variation in eradication rates of group A streptococci by penicillin in multisite clinical trials

Pediatric Infectious Disease Journal

Volumn 26, Issue 12, 2007, Pages 1110-1116

  Kaplan, Edward L ^a,b   Oakes, J Michael ^b   Johnson, Dwight R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Group A streptococci; Multisite clinical trial; Pharyngitis; Streptococcal carrier; Treatment failure; Treatment success

Indexed keywords

PENICILLIN G;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; HUMAN; MAJOR CLINICAL STUDY; PHARYNGITIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 36549037288     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31814615ac     Document Type: Article

References (17)

1. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics. 2001;108:1180-1186.
2. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococci. Pediatrics. 2004;113:866-882.
3. Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004;38:1526-1534.
4. Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics. 2004;113:1816-1819.
5. Bisno AL. Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis. Clin Infect Dis. 2004;38:1535-1537.
6. Dajani AS, Taubert K, Ferrieri P, Peter G, Shulman ST. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Pediatrics. 1995;96:758-764.
7. American Academy of Pediatrics. Report of the Committee on Infectious Diseases. Red Book. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003.
8. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35:113-125.
9. Johnson DR, Kaplan EL, Sramek J, et al. Laboratory Diagnosis of Group A Streptococcal Infections. Geneva, Switzerland: World Health Organization; 1996.
10. Hardin JW, Hilbe JM. Generalized Estimating Equations. New York, NY: Chapman & Hall; 2003.
11. Berk R. Regression Analysis. A Constructive Critique. Thousand Oaks, CA: Sage Publications; 2004.
12. Donner A, Klar N. Design and Analysis of Cluster Randomized Trials in Health Research. London, England: Arnold; 2000.
13. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10:673-695.
14. Kaplan E, Johnson D, del Rosario M, Horn D. Susceptibility of group A beta hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J. 1999;18:1069-1072.
15. Macris MH, Hartman N, Murray B, et al. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J. 1998;17:377-381.
16. Kaplan E, Gastanaduy A, Huwe B. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981;98:326-335.
17. Kaplan EL, Chhatwal GS, Rhode M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398-1406.